TCM
Triumph Capital Management Portfolio holdings
AUM
$409M
1-Year Est. Return
13.6%
1 Year Est. Return
+13.6%
AUM
$409M
AUM Growth
+$75.4M
(+23%)
Holding
1,604
Top Buys
| 1 | +$4.46M | |
| 2 | +$4.36M | |
| 3 | +$3.89M | |
| 4 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$2.41M |
| 5 |
NEOS S&P 500 High Income ETF
SPYI
|
+$1.89M |
Top Sells
| 1 | +$3.48M | |
| 2 | +$2.78M | |
| 3 | +$2.31M | |
| 4 |
CrowdStrike
CRWD
|
+$1.41M |
| 5 |
OXLC
Oxford Lane Capital
OXLC
|
+$1.34M |
Sector Composition
| 1 | Technology | 9.51% |
| 2 | Financials | 7.39% |
| 3 | Consumer Discretionary | 3.9% |
| 4 | Healthcare | 2.54% |
| 5 | Communication Services | 2.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Tilray
TLRY
$853M
| $7 | ﹤0.01% |
+4
|
|
||
1602
GoPro
GPRO
$292M
| $4 | ﹤0.01% |
+2
|
|
||
1603
BioXcel Therapeutics
BTAI
$45.3M
| $3 | ﹤0.01% |
+1
|
|
||
1604
IGC Pharma
IGC
$27.7M
| $1 | ﹤0.01% |
+2
|
|